We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

17 hedge funds and large institutions have $457K invested in Anixa Biosciences in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

13% more funds holding

Funds holding: 15 → 17 (+2)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

42% less capital invested

Capital invested by funds: $788K → $457K (-$331K)

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DIA
Denver Investment Advisors
Colorado
+$64.8K
2
UBS Group
UBS Group
Switzerland
+$12.5K
3
BFA
BlackRock Fund Advisors
California
+$3.64K
4
WA
Winfield Associates
Ohio
+$281
5
Morgan Stanley
Morgan Stanley
New York
+$53

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$76.8K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$53K
3
Deutsche Bank
Deutsche Bank
Germany
-$13K
4
TRCT
Tower Research Capital (TRC)
New York
-$3.02K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$183K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$103K – – –
DIA
3
Denver Investment Advisors
Colorado
$56K +$64.8K +18,480 New
Millennium Management
4
Millennium Management
New York
$42K -$76.8K -21,892 -61%
Morgan Stanley
5
Morgan Stanley
New York
$30K +$53 +15 +0.2%
UBS Group
6
UBS Group
Switzerland
$26K +$12.5K +3,572 +73%
First Manhattan
7
First Manhattan
New York
$7K – – –
ClearBridge Investments
8
ClearBridge Investments
New York
$3K – – –
BFA
9
BlackRock Fund Advisors
California
$3K +$3.64K +1,038 New
Wells Fargo
10
Wells Fargo
California
$2K – – –
Bank of America
11
Bank of America
North Carolina
$1K – – –
EWM
12
Evercore Wealth Management
New York
$1K – – –
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
– -$53K -11,103 Closed
Deutsche Bank
14
Deutsche Bank
Germany
– -$13K -2,930 Closed
TRCT
15
Tower Research Capital (TRC)
New York
– -$3.02K -861 -90%
WAS
16
WESPAC Advisors SoCal
California
– +$140 +40 New
MFW
17
Mosaic Family Wealth
Missouri
– +$281 +80 New
WA
18
Winfield Associates
Ohio
– +$281 +80 New

ANIX Hedge Fund Activity: Q4 2015 in Review

17 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2015, worth a combined $457K — down 42% from $788K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ANIX positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Denver Investment Advisors, opening a new position worth an estimated $64.8K. The largest seller was Millennium Management, cutting an estimated $76.8K.

  • 17 institutional investors held Anixa Biosciences (ANIX) as of Q4 2015, up from 15 in Q3 2015.
  • Funds reported $457K of Anixa Biosciences stock for Q4 2015, down 42% quarter-over-quarter.
  • 5 funds opened new Anixa Biosciences positions in Q4 2015 and 3 closed out, a net change of +2 holders.
  • The largest Anixa Biosciences buyer in Q4 2015 was Denver Investment Advisors, an estimated $64.8K added.
  • The largest Anixa Biosciences seller in Q4 2015 was Millennium Management, an estimated $76.8K sold.

Based on aggregated 13F filings for Q4 2015.